Stéphanie Guidez - Concepedia

Author

Stéphanie Guidez

Centre Hospitalier Universitaire de Poitiers

Also Known As

Christine Giraud, Guidez, S., Guidez, Stephanie, Guidez, Stéphanie, Kamal Bouabdallah, S. GUIDEZ, S. Guidez, Stephanie Guidez, Stéphanie GUIDEZ, Stéphanie Guidez

197

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Poitiers Centre Hospitalier Universitaire de Lille Inserm Assistance Publique – Hôpitaux de Paris Hospices Civils de Lyon

About

Stéphanie Guidez is an author at Centre Hospitalier Universitaire de Poitiers specializing in oncology, immunotherapy, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	60
2	Immunology	2	2	34
3	Health Sciences	1	1	26
4	Blood Transplantation	1	1	20
5	Molecular Medicine	1	1	26

Stéphanie Guidez

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma Emmanuel Bachy, Steven Le Gouill, Roberta Di Blasi, Nature Medicine	2022	343
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA) Emmanuel Bachy, Vincent Camus, Catherine Thiéblemont, Journal of Clinical Oncology	2021	179
The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma Clémentine Sarkozy, Sarah Huet, Victoria Carlton, Oncotarget	2017	95
<i>TP53</i> Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia Stéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, Clinical Cancer Research	2017	91
Impact of Initial FDG-PET/CT and Serum-Free Light Chain on Transformation of Conventionally Defined Solitary Plasmacytoma to Multiple Myeloma Guillemette Fouquet, Stéphanie Guidez, Charles Herbaux, Clinical Cancer Research	2014	73
Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R<sup>2</sup>) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma Franck Morschhauser, Loretta J. Nastoupil, Pierre Feugier, Journal of Clinical Oncology	2022	61
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma Tae Min Kim, Michał Taszner, Silvana Novelli, Annals of Oncology	2024	60
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Blood	2024	49
Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers Sylvain Chantepie, Sylvain Garciaz, Emmanuelle Tchernonog, American Journal of Hematology	2018	42
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma Eileen M. Boyle, Guillemette Fouquet, Stéphanie Guidez, Cancer	2014	36

Page 1